In the ongoing push to improve outcomes after acute MI, Swedish investigators are probing a new angle: could identification and treatment of Helicobacter pylori cut down on gastrointestinal bleeds in ...

Helicobacter pylori (H. pylori) is a type of bacteria that infects the stomach and small bowel. It is often symptomless, but it can increase the risk of ulcers, gastritis, and cancer, all of which can ...

Bismuth quadruple therapy for 14 days is preferred regimen for treatment-naive patients when antibiotic susceptibility is unknown. William D. Chey, MD, from Michigan Medicine in Ann Arbor, and ...

| DelveInsight The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based ...

In elderly patients, recommendations were similar to those for the general population, however with increased monitoring; sequential therapy (amoxicillin and rabeprazole for 5 days followed by ...

(HealthDay)—Among those who have Helicobacter pylori infection and a family history of gastric cancer in first-degree relatives, eradication treatment for H. pylori reduces the risk for gastric cancer ...

Several Twitter users on Thursday, November 25, took to the micro-blogging site to narrate their experiences with bacteria Helicobacter pylori (H. Pylori). The users observed that H. Pylori seems to ...

The helicobacter pylori (H. pylori) bacteria, a common bug that can cause stomach infections, developed a high resistance to key antibiotics in the two years since the pandemic started, a small new ...

USPTO issues new patent covering Talicia[1] as a method for eradicating H. pylori regardless of patient Body Mass Index (BMI)[2], supporting Talicia protection until May 2042 The patent is supported ...

(RTTNews) - RedHill Biopharma Ltd. (RDHL) Monday said the U.S. Patent and Trademark Office (USPTO) has granted new patent for Talicia indicated for the treatment of Helicobacter pylori (H. pylori) ...

Helicobacter pylori bacteria is considered to be the main cause of gastric cancer, with the infection rate particularly high in the Asia-Pacific region. Approximately 90% of cases are linked to H.

The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based therapies ...